Your browser doesn't support javascript.
loading
Development of orally active oxytocin antagonists: studies on 1-(1-[4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl]piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridines.
Bell, I M; Erb, J M; Freidinger, R M; Gallicchio, S N; Guare, J P; Guidotti, M T; Halpin, R A; Hobbs, D W; Homnick, C F; Kuo, M S; Lis, E V; Mathre, D J; Michelson, S R; Pawluczyk, J M; Pettibone, D J; Reiss, D R; Vickers, S; Williams, P D; Woyden, C J.
Affiliation
  • Bell IM; Department of Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania 19486, USA.
J Med Chem ; 41(12): 2146-63, 1998 Jun 04.
Article in En | MEDLINE | ID: mdl-9622556
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Oxazines / Pyridines / Receptors, Oxytocin Language: En Journal: J Med Chem Year: 1998 Document type: Article
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Oxazines / Pyridines / Receptors, Oxytocin Language: En Journal: J Med Chem Year: 1998 Document type: Article